Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-01-06 @ 1:59 PM
Study NCT ID:
NCT03141060
Status:
COMPLETED
Last Update Posted:
2025-06-10
First Post:
2017-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-01
First Submit QC Date:
None
Study First Post Date:
2017-05-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-06
Last Update Post Date:
2025-06-10
Last Update Post Date Type:
ACTUAL